Evidence map›Paper›PMID 26439695›Full record

ArticleOncotarget2015

Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.

Man-Hung Eric Tang, Malin Dahlgren, Christian Brueffer, Tamara Tjitrowirjo, Christof Winter, Yilun Chen, Eleonor Olsson, Kun Wang, Therese Törngren, Martin Sjöström and 7 more

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Neoadjuvant Therapy for Breast Cancer as a Model for Translational Research.Breast cancer : basic and clinical research · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Man-Hung Eric TangDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Malin DahlgrenDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Christian BruefferDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Tamara TjitrowirjoDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Christof WinterDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Yilun ChenDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Eleonor OlssonDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Kun WangDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Therese TörngrenDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Martin SjöströmDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Dorthe GrabauDepartment of Pathology, Skåne University Hospital, Lund, Sweden.
Pär-Ola BendahlDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lisa RydénDivision of Surgery, Department of Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden.
Emma NiméusDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lao H SaalDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Åke BorgDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Sofia K Gruvberger-SaalDivision of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University · SESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To better understand and characterize chromosomal structural variation during breast cancer progression, we enumerated chromosomal rearrangements for 11 patients by performing low-coverage whole-genome sequencing of 11 primary breast tumors and their 13 matched distant metastases. The tumor genomes harbored a median of 85 (range 18-404) rearrangements per tumor, with a median of 82 (26-310) in primaries compared to 87 (18-404) in distant metastases. Concordance between paired tumors from the same patient was high with a median of 89% of rearrangements shared (range 61-100%), whereas little overlap was found when comparing all possible pairings of tumors from different patients (median 3%). The tumors exhibited diverse genomic patterns of rearrangements: some carried events distributed throughout the genome while others had events mostly within densely clustered chromothripsis-like foci at a few chromosomal locations. Irrespectively, the patterns were highly conserved between the primary tumor and metastases from the same patient. Rearrangements occurred more frequently in genic areas than expected by chance and among the genes affected there was significant enrichment for cancer-associated genes including disruption of TP53, RB1, PTEN, and ESR1, likely contributing to tumor development. Our findings are most consistent with chromosomal rearrangements being early events in breast cancer progression that remain stable during the development from primary tumor to distant metastasis.

Indexed as

Chromosome AberrationsGene RearrangementGenome, HumanAdultAgedBiomarkers, TumorBreast NeoplasmsChromosomes, HumanFemaleHigh-Throughput Nucleotide SequencingHumansMiddle AgedNeoplasm MetastasisReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, MessengerBiomarkers, TumorRNA, Messengerbreast cancerchromosomal rearrangementschromothripsismetastasiswhole-genome sequencing

Identifiers

PMID26439695
PMCPMC4741922
OpenAlexW1946158680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.